EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Innovations in Hidradenitis Suppurativa

Sarah E Park, Jennifer L Hsiao, Maria A Aleshin

Dermatologic Clinics · 2025

DOI: 10.1016/j.det.2024.08.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Dermatologic Clinics, 2025. Verfasst von Sarah E Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa. Die Arbeit nennt 71 Literaturangaben. Gefördert von: AbbVie, Novartis Pharmaceuticals Corporation, School of Public Health, University of California Berkeley.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by painful, recurrent abscesses, inflammatory nodules, and draining tunnels. Biologic and small molecule therapeutics are effective for treatment of moderate-to-severe HS. The field of HS is rapidly growing with numerous ongoing clinical trials exploring novel agents. This review highlights the latest discoveries in the field of HS, with a particular focus on novel therapeutic agents and procedural management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaHumansDermatologic AgentsBiological ProductsAnti-Bacterial Agents

Stichwörter der Autor:innen

BiologicsHidradenitis suppurativaInnovationsSmall molecules

Substanzen

Dermatologic AgentsBiological ProductsAnti-Bacterial Agents

Autor:innen und Institutionen

  • David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
  • Department of Dermatology, University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA 90033, USA.
  • Department of Dermatology, Stanford University School of Medicine, 450 Broadway Street, Pavilion B, 4th Floor, Redwood City, CA 94063, USA. Electronic address: maleshin@stanford.edu.

Förderung

  • AbbVie
  • Novartis Pharmaceuticals Corporation
  • School of Public Health, University of California Berkeley

Zitieren

APA

Park, S. E., Hsiao, J. L., & Aleshin, M. A. (2025). Innovations in Hidradenitis Suppurativa. Dermatologic Clinics. https://doi.org/10.1016/j.det.2024.08.003

Vancouver

Park SE, Hsiao JL, Aleshin MA. Innovations in Hidradenitis Suppurativa. Dermatologic Clinics. 2025. doi:10.1016/j.det.2024.08.003

BibTeX
@article{Park2025,
  author = {Park, Sarah E and Hsiao, Jennifer L and Aleshin, Maria A},
  title = {Innovations in Hidradenitis Suppurativa},
  journal = {Dermatologic Clinics},
  year = {2025},
  doi = {10.1016/j.det.2024.08.003}
}
Kostenlos starten →